Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/29/2007US20070275382 Biomarkers for the Efficacy of Somatostatin Analogue Treatment
11/29/2007US20070275368 Posh Associated Kinases And Related Methods
11/29/2007US20070275367 Type lectin fold as a scaffold for massive sequence variation
11/29/2007US20070275366 Regulation of Sperm Function
11/29/2007US20070275110 Botulinum Toxin Treatment Of Spastic Bladder
11/29/2007US20070275102 Method of affecting sleep and sleep-related behaviors
11/29/2007US20070275095 Treatment of inflammatory, autoimmune, or other disorders, using agents that reduce the sequestering of zinc by calprotectin
11/29/2007US20070275092 Therapeutic composition supporting the immune system
11/29/2007US20070275091 Compositions And Methods For Improved Mucus Function
11/29/2007US20070275086 Use of Increased Molecular-Weight Hirudin as an Anticoagulant in Extracorporeal Kidney Replace Therapy
11/29/2007US20070275084 Compositions And Methods For The Treatment Of Skin Damage
11/29/2007US20070275083 ameliorating chronic renal insufficiency, hypertension, atherosclerosis, and chronic congestive heart failure
11/29/2007US20070275082 Preparation Method for Sustained Release Microspheres Using a Dual-Feed Nozzle
11/29/2007US20070275079 Antigen-Containing Microspheres for the Treatment of Allergies
11/29/2007US20070275078 Microcapsules for the Administration of Active Ingredients
11/29/2007US20070275071 Use of Microparticles for Antigen Delivery
11/29/2007US20070275069 Hydrophobic biomolecular structure
11/29/2007US20070275055 Compositions capable of facilitating penetration across a biological barrier
11/29/2007US20070275050 Method for treating blood coagulation disorders
11/29/2007US20070275045 Composition for the treatment of warts and molluscum contagiosum
11/29/2007US20070275036 Avian follistatin product
11/29/2007US20070275032 Use Of A Mixture For The Production Of An Agent For Treating Defective Or Degenerated Cartilage In The Production Of Natural Cartilage Replacement In Vitro
11/29/2007US20070275028 Injectable fibrin composition for bone augmentation
11/29/2007US20070275027 Microparticle containing matrices for drug delivery
11/29/2007US20070275026 Therapeutic Use of a Growth Factor, NsG33
11/29/2007US20070275004 Group b streptococcus antigens
11/29/2007US20070275003 polynucleotides that code for HPV E6/E7 fusion proteins, having mutagenesis points, used to generate immune responses against HPV and prevent or treat cervical cancer
11/29/2007US20070275000 Tick Engorgement Factor Proteins
11/29/2007US20070274999 Method of treating disorders using platelet glycoprotein Ib alpha fusion polypeptides
11/29/2007US20070274996 IL-4R antagonists; allergies and asthma
11/29/2007US20070274995 Cardiotrophin-1 compositions and methods for the treatment of tumor
11/29/2007US20070274994 Virulence-Associated Adhesins
11/29/2007US20070274992 Secreted Protein Family
11/29/2007US20070274989 Methods and Compositions for the Prevention and Treatment of Sepsis
11/29/2007US20070274988 Kiaa0779, Splice Variants Thereof, and Methods of Their Use
11/29/2007US20070274987 Expression of the cysteine protease legumain in vascular and inflammatory diseases
11/29/2007US20070274980 Compositions of less immunogenic and long-circulating protein-lipid complexes
11/29/2007US20070274979 Compositions and Methods for Promoting Neuronal Outgrowth
11/29/2007US20070274978 Method of Killing Spores
11/29/2007US20070274977 Methods for Lowering Elevated Uric Acid Levels Using Intravenous Injections of PEG-Uricase
11/29/2007US20070274976 Ethanol dependence of alpha1 antitrypsin c-terminal lys truncation by basic carboxypeptidases
11/29/2007US20070274953 Photochemical internalization for delivery of molecules into the cytosol
11/29/2007US20070274951 Combinations comprising HCV protease inhibitor(s) and HCV polymerase inhibitor(s), and methods of treatment related thereto
11/29/2007US20070274950 Interferon-alpha polypeptides and conjugates
11/29/2007US20070274948 Methods of Therapy for Chronic Lymphocytic Leukemia
11/29/2007US20070274947 Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1 and Uses Thereof in the Treatment of Cancer
11/29/2007US20070274946 Tolerance to Graft Prior to Thymic Reactivation
11/29/2007US20070274921 Diagnostics and therapeutics for ocular disorders
11/29/2007US20070274912 Histone Modifications as Binary Switches Controlling Gene Expression
11/29/2007DE68907430C5 Cytotoxische Therapie. Cytotoxic therapy.
11/29/2007DE19531342B4 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators
11/29/2007DE10259834B4 Test und Screeningverfahren zur Identifizierung von Inhibitoren von Beta-Sekretasen Test and screening methods for identifying inhibitors of beta secretases
11/29/2007CA2669813A1 Substituted aryl piperidinylalkynyladenosines as a2ar agonists
11/29/2007CA2657965A1 Methods of treating acute blood loss
11/29/2007CA2653456A1 Permeability of blood-brain barrier
11/29/2007CA2653154A1 Prolonged fix analogues and derivatives
11/29/2007CA2652983A1 Use of proinsulin for the preparation of a neuroprotective pharmaceutical composition, therapeutic composition containing it and applications thereof
11/29/2007CA2652675A1 Chondroitin sulfate degradation to ameliorate brain damage induced by hypoxia
11/29/2007CA2652600A1 Use of cathepsin k antagonists in bone production
11/29/2007CA2652578A1 Erythropoietin compositions
11/29/2007CA2652432A1 .gamma.-l-pga producing microorganism, method of producing .gamma.-l-pga using the microorganism, crosslinked substance produced using the microorganism, and external dermal agentproduced using the microorganism
11/29/2007CA2649810A1 Cladribine regimen for treating multiple sclerosis
11/29/2007CA2648889A1 Use of thymosin alpha 1 for the treatment of immunological diseases
11/29/2007CA2640671A1 Engineered antibody-stress protein fusions
11/28/2007EP1860190A2 Neutrokine-alpha and neutrokine-alpha splice variants
11/28/2007EP1860189A1 Human gene
11/28/2007EP1860188A2 Human cytokine receptor
11/28/2007EP1860187A1 Apo-2 receptor
11/28/2007EP1860118A2 Immunoadhesin comprising a glycoprotein VI domain
11/28/2007EP1860116A1 Trehalose conjugate with carnosine having antioxidant activity, stable to enzymatic hydrolysis, procedure for its preparation, and pharmaceutical, cosmetic and nutraceutical compositions that contain it
11/28/2007EP1859813A1 Remedy for disease associated with apoptotic degeneration in ocular cell tissue with the use of siv-pedf vector
11/28/2007EP1859805A2 Peptides and peptide analogues designed from the HFE protein and their uses in the treatment of iron overload diseases
11/28/2007EP1859804A1 Anticancer agent to be combined with telomelysin
11/28/2007EP1859277A2 Treating neurological disorders
11/28/2007EP1858927A2 Methods and uses of antibodies in the purification of interferon
11/28/2007EP1858926A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
11/28/2007EP1858923A1 A molecule and chimeric molecules thereof
11/28/2007EP1858920A2 Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
11/28/2007EP1858919A2 Immunogens from uropathogenic escherichia coli
11/28/2007EP1858913A2 Mimetic peptides and the use thereof in the form of 20s, 26s and immunoproteasome inhibitors
11/28/2007EP1858558A2 Nod1 as an anti-tumor agent
11/28/2007EP1858546A2 Modified transferrin fusion proteins
11/28/2007EP1858545A2 Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
11/28/2007EP1858544A2 Il-10 related peptides for wound healing
11/28/2007EP1858542A2 Compositions and methods for treating vascular permeability
11/28/2007EP1858541A2 Use of modulators of compounds of tgf-beta superfamily to regulate hepcidin-mediated iron metabolism
11/28/2007EP1858540A2 Stabilized compositions containing natriuretic peptides
11/28/2007EP1858539A2 Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors
11/28/2007EP1858538A2 Mucin hypersecretion inhibitors based on the structure of mans and methods of use
11/28/2007EP1858537A2 Prion-specific peptide reagents
11/28/2007EP1858532A1 Compositions and methods for less immunogenic protein formulations
11/28/2007EP1858497A2 Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization
11/28/2007EP1858355A1 High pressure processing of metal ion lactoferrin
11/28/2007EP1691844A4 Methods and compositions for treatment of interferon-resistant tumors
11/28/2007EP1618212B1 Mutations in the human pcsk9 gene associated to hypercholesterolemia
11/28/2007EP1562626B1 Stabilized, solid-state polypeptide particles
11/28/2007EP1545620B1 Pharmaceutical compositions comprising cyclosporin for oral administration
11/28/2007EP1542710A4 Methods for preserving organs and tissues
11/28/2007EP1539224B1 Antimicrobial composition and method for use
11/28/2007EP1480691A4 Agglomerated particles for aerosol drug delivery
1 ... 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 ... 3163